CSL Hong Kong Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1000IU complex, Powder for injection (50 IU/mL FVIII)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

Von willebrand factor, Quantity: 1000 IU; Factor VIII, Quantity: 500 IU

Beschikbaar vanaf:

CSL Behring Australia Pty Ltd

INN (Algemene Internationale Benaming):

Factor VIII,Von willebrand factor

farmaceutische vorm:

Injection, solution

Samenstelling:

Excipient Ingredients: water for injections

Toedieningsweg:

Intravenous

therapeutische indicaties:

Aleviate is indicated for: ? the treatment of bleeding episodes including surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the treatment and prophylaxis of bleeding associated with factor FVIII deficiency due to haemophilia A.

Product samenvatting:

Visual Identification: Clear, colourless solution; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorisatie-status:

Listed (Export Only)

Autorisatie datum:

2004-06-17